Louisiana State University

LSU Digital Commons
Faculty Publications

Department of Physics & Astronomy

12-1-2020

Comparison of conventional and advanced radiotherapy
techniques for left-sided breast cancer after breast conserving
surgery
Yibo Xie
Louisiana State University

Daniel Bourgeois
Mary Bird Perkins Cancer Center

Beibei Guo
Louisiana State University

Rui Zhang
Louisiana State University

Follow this and additional works at: https://digitalcommons.lsu.edu/physics_astronomy_pubs

Recommended Citation
Xie, Y., Bourgeois, D., Guo, B., & Zhang, R. (2020). Comparison of conventional and advanced radiotherapy
techniques for left-sided breast cancer after breast conserving surgery. Medical Dosimetry, 45 (4), e9-e16.
https://doi.org/10.1016/j.meddos.2020.05.004

This Article is brought to you for free and open access by the Department of Physics & Astronomy at LSU Digital
Commons. It has been accepted for inclusion in Faculty Publications by an authorized administrator of LSU Digital
Commons. For more information, please contact ir@lsu.edu.

HHS Public Access
Author manuscript
Author Manuscript

Med Dosim. Author manuscript; available in PMC 2021 July 07.
Published in final edited form as:
Med Dosim. 2020 ; 45(4): e9–e16. doi:10.1016/j.meddos.2020.05.004.

Comparison of conventional and advanced radiotherapy
techniques for left-sided breast cancer after breast conserving
surgery
Yibo Xie, PhDa, Daniel Bourgeois, MDb, Beibei Guo, PhDc, Rui Zhang, PhDa,b,**

Author Manuscript

aDepartment

of Physics and Astronomy, Louisiana State University, Baton Rouge, LA, USA

bDepartment

of Radiation Oncology, Mary Bird Perkins Cancer Center, Baton Rouge, LA, USA

cDepartment

of Experimental Statistics, Louisiana State University, Baton Rouge, LA, USA

Abstract
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Whole breast radiotherapy (WBRT) after breast conserving surgery is the standard treatment to
prevent recurrence and metastasis of early stage breast cancer. This study aims to compare seven
WBRT techniques including conventional tangential, field-in-field (FIF), hybrid intensitymodulated radiotherapy (IMRT), IMRT, standard volumetric modulated arc therapy (STD-VMAT),
non-coplanar VMAT (NC-VMAT) and multiple arc VMAT (MA-VMAT). Fifteen patients who
were previously diagnosed with left-sided early stage breast cancer and treated in our clinic were
selected for this study. WBRT plans were created for these patients and were evaluated based on
target coverage and normal tissue toxicities. All techniques produced clinically acceptable WBRT
plans. STD-VMAT delivered the lowest mean dose (1.1 ± 0.3 Gy) and the lowest maximum dose
(7.3 ± 4.9 Gy) to contralateral breast, and the second lowest LAR (4.1 ± 1.4%) of secondary
contralateral breast cancer. MA-VMAT delivered the lowest mean dose to lungs (4.9 ± 0.9 Gy) and
heart (5.5 ± 1.2 Gy), exhibited the lowest LAR (1.7 ± 0.3%) of secondary lung cancer, NTCP (1.2
± 0.2%) of pneumonitis, RCE (10.3 ± 2.7%), and LAR (3.9 ± 1.3%) of secondary contralateral
breast cancer. NC-VMAT plans provided the most conformal target coverage, the lowest
maximum lung dose (46.2 ± 4.1 Gy) and heart dose (41.1 ± 5.4 Gy), and the second lowest LAR
(1.8 ± 0.4%) of secondary lung cancer and RCE (10.5 ± 2.8%). MA-VMAT and NC-VMAT could
be the preferred techniques for early stage breast cancer patients after breast conserving surgery.
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Introduction
Breast cancer has the highest incidence rate among women in the US other than skin cancer
(www.cancer.org). Women who were diagnosed with early-stage breast cancer and had
lumpectomy usually underwent whole breast radiation therapy (WBRT) after surgery, which
could lower recurrence and metastasis rates and make lumpectomy as effective as
mastectomy.1
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The current standard of care (SOC) for WBRT in the US is using parallel-opposed tangential
photon fields to treat the whole ipsilateral breast and chest wall, plus additional photon and
electron fields to treat supraclavicular, axillary and internal mammary nodes when
necessary.2 However, significant dose inhomogeneity can occur within the irradiated volume
and can cause poor cosmetic outcomes, especially for women with large breasts.3–5 Field-infield (FIF) technique is used sometimes to improve dose homogeneity throughout the target
volume.3, 6 Intensity-modulated radiation therapy (IMRT) has been used for WBRT and can
improve dose conformity and homogeneity, reduce high dose to heart and lung at the
expense of increasing overall low doses,7 and has been shown to decrease acute skin
toxicity.8 Hybrid IMRT (combination of open tangential and IMRT beams) has been shown
to have a good balance of plan complexity and dose coverage/OAR sparing.9–11 Volumetric
modulated arc therapy (VMAT) can achieve similar target coverage as IMRT, spare more
normal tissues and can significant reduce treatment time.12 Multiple arc VMAT (MAVMAT) showed good feasibility and OAR sparing for WBRT.13 Non-coplanar VMAT (NCVMAT) has been shown to improve OAR dosimetry for post-mastectomy breast cancer14
and partial breast cancer,15–18 but has not been evaluated for WBRT.
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The purpose of this study was to compare target coverage and risks of developing of
radiogenic side effects for a sample of WBRT patients using various modalities, including
SOC, FIF, hybrid IMRT, IMRT, VMAT, MA-VMAT and NC-VMAT. There have been
multiple treatment planning studies of WBRT,19–28 but most of them did not include hybrid
IMRT in the comparison although hybrid IMRT had been recommended as the optimal
technique for WBRT10; with the advance of inverse planning techniques, the differences in
treatment plan outcomes should be evaluated among different VMAT techniques while none
of the previous studies did so; in addition, the radiobiological metrics like normal tissue
complication probability (NTCP) of pneumonitis, lifetime attributable risk (LAR) of second
cancers, and risk of coronary events (RCE) should be evaluated and compared among
various WBRT modalities because it has been shown inclusion of non-dosimetric factors can
provide a more robust comparison of different radiotherapy techniques,29 while most of the
previous studies only performed dosimetric comparisons.
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Methods and Materials
Patient selection
Fifteen early stage left-sided breast cancer patients presenting for WBRT without nodal
involvement after breast conserving surgery were included in this study. Computed
tomography (CT) scans were obtained when patients were immobilized on a breast wing
board with the left arm elevated above the head and free-breathing, and all CT data were
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anonymized30 for this study. The target definitions were based on RTOG breast cancer Atlas
and were approved by a radiation oncologist: clinical target volume (CTV) was defined as
the ipsilateral breast with 5 mm skin extraction; planning target volume (PTV) was defined
as CTV plus 7 mm expansion; PTV-Eval was based on PTV and defined to be limited
anteriorly to exclude the part outside the patient and the first 5 mm of tissue under the skin,
and posteriorly no deeper to the anterior surface of the ribs, and PTV-Eval was used in
planning and for dose analysis. The contours of organs at risk (OARs) for each patient were
approved by the same radiation oncologist and included lungs, whole heart and contralateral
breast.
Treatment planning
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The prescription dose for all patients was 50 Gy in 25 fractions. The following criteria were
required for each treatment plan to be clinically acceptable: the volume of the PTV receiving
at least 95% of the prescribed dose is greater than or equal to 95%; the volume of left lung
receiving at least 20 Gy is less than 20%31; the volume of heart receiving at least 22.5 Gy is
less than 20%.32 Maximum and mean doses for heart, lung and contralateral breast were
constrained. All plans were generated in a commercial treatment planning system (TPS)
(Pinnacle3 v9.8, Philips Medical Systems, Fitchburg, WI, USA).
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SOC plans included two opposed tangential beams of 6, 10 or 15 MV energy depending on
patient’s anatomy, and the tangential beam angles were determined by the fiducial markers
placed on the skin and were usually around anterior midsternum and ipsilateral lower axilla.
Collimator was rotated to shield the heart and lung, and dynamic wedges were used to
minimize hotspots within PTV-Eval. FIF, hybrid IMRT and IMRT plans utilized the same
beam energies as SOC plans. FIF plans used the same beam angles as SOC plans, and two to
three subfields per beam were manually added using multi-leaf collimators (MLCs) to
eliminate hotspots after the open field plan was created.6 Hybrid IMRT plans included a pair
of open tangent fields and a pair of dynamic IMRT tangent fields, and 80% of prescription
dose was delivered by open tangent beams and 20% of the prescription dose was delivered
by IMRT beams.11 IMRT plans were generated using the direct machine parameter
optimization (DMPO) algorithm, and included seven coplanar beam equidistantly distributed
in a sector of 180° that avoided direct exposure to the contralateral breast. All STD-VMAT,
NC-VMAT and MA-VMAT plans used 6 MV beam energy and were generated using the
SmartArc optimization algorithm. STD-VMAT plans utilized two coplanar partial arcs: the
first arc was planned to be delivered counterclockwise (CCW) with starting and stopping
gantry angles same as tangential fields, and the second arc was planned to be delivered
clockwise (CW) over the same range of gantry angle. NC-VMAT plans utilized two partial
arcs: the first arc was planned to be delivered CCW with starting and stopping gantry angles
same as tangent fields and with 20° couch angle, and the second arc was planned to be
delivered CW over the same range of gantry angle and with 340° couch angle. The
collimator was rotated to align with the long axis of PTV in both arcs.33 MA-VMAT plans
consisted of six partial arcs (ARC01 to ARC06), each with 50°gantry rotations.13 ARC01 to
ARC03 were delivered CW and ARC04 to ARC06 were delivered CCW. The starting angle
of ARC01 and stopping angle of ARC03 were the same as SOC technique. The collimator
was always rotated to align with the long axis of PTV in each arc.
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Dosimetric parameters were evaluated for target, lungs, heart and contralateral breast. Dose
homogeneity index (DHI)34 and conformity index (CI)35 were evaluated for PTV-Eval.
Risks of radiogenic side effects were assessed: LAR was computed for secondary lung
cancer and contralateral breast cancer using BEIR VII model36 and organ equivalent dose
(OED)37. NTCP for pneumonitis was evaluated using Lyman-Kutcher-Burman (LKB)
model38–40. Dose-response model in Darby et al.41 was used to evaluate RCE for each
patient and Reynolds risk model42 was used to calculate the baseline risk assuming medium
risk type. More details of dose-risk models can be found in our previous study.14
The post hoc Tukey test was used to determine the statistical significance of the differences
between two WBRT techniques. All statistical analyses were conducted with R software
(version 3.2.3) and any difference was considered significant when p < 0.05.
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Results
The axial dose distributions and DVHs for a typical WBRT patient are shown in Figs. 1 and
2. Table 1 lists PTV and OARs evaluation metrics for various WBRT techniques. The results
of statistical tests are shown in Table 2 where the grey color indicates statistically
significance (p values <0.05), e.g., SOC has significantly higher V107% for PTV, Dmean,
Dmax, V20 and NTCP for lung, V22.5 and V30 for heart, Dmean and V5 for contralateral breast
compared to IMRT, STD-VMAT, NC-VMAT and MA-VMAT plans; SOC has significantly
higher Dmax and V107% for PTV compared to FIF and hybrid IMRT plans; STD-VMAT has
significantly higher V5 for lung and heart compared to other six WBRT techniques; no
statistically significance shown in any comparison between FIF and hybrid IMRT.
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By combining the results from Table 1 and Table 2, we found that all seven WBRT
techniques analyzed in this study meet clinical requirement of PTV coverage; SOC plans
introduce significantly larger hot spots in PTV by showing the highest V107%, and deliver
relatively higher dose to OARs than inverse planning techniques (IMRT, STD-VMAT, NCVMAT and MA-VMAT); FIF and hybrid IMRT plans exhibit better PTV coverage than
SOC, deliver relatively lower dose to OARs than SOC, and both show relatively better dose
homogeneity in PTV than the other five techniques; STD-VMAT plans provide the lowest
Dmean and Dmax for contralateral breast, and the second lowest LAR of secondary cancer in
contralateral breast, but significantly increase the low dose cloud like V5 for lung and heart;
MA-VMAT plans show the lowest Dmean, V10, NTCP and LAR for lung, the lowest V5 and
LAR for contralateral breast, and the lowest Dmean, V5, V10, and RCE for heart; NC-VMAT
plans provide the most conformal target coverage, the lowest Dmax, V20 and the second
lowest NTCP and LAR for lung, the lowest Dmax, V22.5, V30 and the second lowest RCE for
heart compared with other techniques.

Discussion
We evaluated seven WBRT techniques for treating left-sided lumpectomy breast cancer
patients. All seven techniques provide clinical acceptable dose coverage to the target
volume. For the two forward planning techniques, FIF plans not only show better PTV
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coverage but also reduce OAR dose than SOC. Five inverse planning techniques show lower
OAR doses than the two forward planning techniques. STD-VMAT plans spare contralateral
breast well at the cost of larger low dose cloud for lung and heart. MA-VMAT plans show
the most optimal OARs doses and minimum risk of developing late side effects among all
techniques. NC-VMAT plans provide the most conformal PTV coverage and excellent
sparing of lung and heart.
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There are plenty of WBRT planning studies in the literature. Considering it is difficult to
compare studies with different target definitions, we compared our study with previous work
that had the same PTV delineation based on RTOG as ours (Table 3): Descovich et al.43
concluded that hybrid IMRT can reduce the hot spot within PTV compared to FIF for leftsided breast cancer patients and can provide better coverage, which is consistent with our
results; Jin et al.19 reported that tangential IMRT has the best balance of target coverage and
normal tissue sparing compared with conventional tangential beams, FIF, multi-beam IMRT
and VMAT for small breast size, while our study shows IMRT provides inferior target
coverage or OAR sparing than VMAT especially the advanced VMAT techniques, which is
mainly because the mean PTV volume in our study (910.2 ± 439.8 cc) is much larger than
theirs (360.8 ± 149.1 cc). These results show that tangential IMRT may not be the optimal
technique for all WBRT patients, and its application should be assessed based on patient’s
anatomy; Schubert et al.22 and Haciislamoglu et al.25 both concluded that Tomotherapy
(TOMO) may reduce high doses to heart and lung at the cost of increased low dose cloud
which may lead to an increased probability of radiogenic side effects, and Han et al.21
concluded that TOMO is recommended for WBRT compared to SOC, FIF, IMRT and
VMAT since it exhibits lowest total LAR for OARs. Our study didn’t evaluate TOMO, but
shows NC-VMAT and MA-VMAT have comparable or better sparing of OARs than TOMO,
e.g. NC-VMAT and MA-VMAT deliver mean lung dose of 5.4 ± 1.1 Gy and 4.9 ± 0.9 Gy,
respectively, and mean contralateral breast dose of 1.2 ± 0.7 Gy and 1.2 ± 0.4 Gy,
respectively, while Haciislamoglu et al.25 reported mean lung dose of 9.6 ± 2.0 Gy and mean
contralateral breast dose of 3.1 ± 0.4 Gy for TOMO. This suggests that NC-VMAT and MAVMAT could be used as good alternatives when TOMO System is not available; Zhang et al.
27 evaluated different IMRT techniques and recommended FIF-DMPO-IMRT because it can
reduce doses to lungs and heart and decrease treatment time. Their FIF-DMPO-IMRT
consists of 70~80% FIF and 20%~30% IMRT, which is similar to our hybrid IMRT
technique that has 80% open tangent beams and 20% IMRT, but they required 95% volume
of PTV to receive 100% of prescription dose which makes their dosimetric results not
comparable to ours; Viren et al.26 concluded that both tangential VMAT (tVMAT) with two
dual arcs of 50°−60° and continuous VMAT (cVMAT) with a dual arc of 240° have
improved DHI within PTV and better sparing of heart and ipsilateral lung tissues compared
to FIF and tangential IMRT, and cVMAT provided the best target coverage at the cost of
significantly increased dose to contralateral breast. In our study, STD-VMAT (dual arc of
approximately 180°) also has improved DHI within PTV and better sparing of heart and lung
compare to FIF, and STD-VMAT has much better sparing of contralateral breast (mean dose
1.1 Gy) than their cVMAT (mean dose 2.6 Gy) and is similar to their tVMAT (mean dose
1.2 Gy), which suggests that smaller arcs of VMAT can lower the dose to contralateral
breast.
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Jeulink et al.10 illustrated that hybrid IMRT is most optimal WBRT technique compared
with full IMRT, STD-VMAT and MA-VMAT for the best reduction of mean and low OARs
doses, while it is not the most optimal choice in our study. This is possibly because only two
tangential IMRT fields are used for hybrid IMRT in our study whereas four tangential IMRT
fields were used in theirs. Moreover, left anterior descending coronary artery (LAD) was
contoured as an OAR for plan optimization in their study, which may further limit dose to
the heart but may significantly increase workload for physicians and dosimetrists.
Additionally, the PTV delineation is different since the boost PTV was included in their
analysis. These results suggest that hybrid IMRT may not be the best choice for all WBRT
patients and its application should be determined based on all clinical factors.
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Among all WBRT techniques in our study, MA-VMAT and NC-VMAT have shown superior
OARs sparing. Tsai et al.13 reported mean heart dose of 7.6 ± 1.4 Gy and lung dose of 5.6 ±
0.4 Gy for MA-VMAT, which were slightly higher than our mean heart dose (5.5 ± 1.2 Gy)
and lung dose (4.9 ± 0.9 Gy). This can be explained by the fact that a slightly higher
prescription dose (50.4 Gy delivered in 28 fractions) was used in their study, and different
dose constrains were used, e.g. our mean heart dose limit is 7 Gy while their mean heart
dose limit was 9 Gy. When multiple arcs were used and collimator angle was adjusted for
each arc, treatment plans could be further optimized since more degrees of freedom were
provided for MA-VMAT. Smyth et al.44 summarized the recent advancement in noncoplanar radiotherapy and listed different techniques including static couch NC-VMAT,
coronal VMAT, trajectory VMAT and dynamic wave arc etc. Our study utilizes static couch
NC-VMAT, according to definitions in Smyth et al.44, for WBRT for the first time and
shows it can provide excellent sparing of lung and heart compared to other WBRT
techniques, which demonstrates that OARs can be spared more by adjusting the couch angle
to minimize direct irradiation.
There is a lack of clinical outcome data of radiogenic late effects for advanced WBRT
techniques, but our calculated RCE and LARs for SOC WBRT show good agreement with
clinical data for breast cancer patients who went through SOC WBRT: Taylor et al.45
reported the annual risk of developing radiogenic lung cancer and contralateral breast cancer
was 0.2% and 0.36%, respectively, and our calculated annual risk is 0.22% and 0.38% for
SOC; Hooning et al.46 reported the annual cardiac toxicity was 1.19% whereas our
estimation is 1.23% for SOC. Based on these good agreements, we expect our estimated
radiogenic risks values for advanced WBRT techniques to be reasonable. Prospective
clinical studies can validate our calculations and further illustrate the benefit of advanced
WBRT techniques.
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Cardiac toxicity is a major concern for breast cancer patients who received radiotherapy,
especially for left-sided breast cancer patients.41 Our study shows comparable mean heart
dose for FIF, IMRT and VMAT as those reported by Viren et al.26. However, our study
shows higher mean heart dose for conventional SOC, FIF, IMRT and VMAT than those in
Jin et al.19, which is possibly because their extra dose constrains on coronary artery has
further limited heart dose, and the larger breast size in our study could inevitably lead to
larger fields that will induce higher heart dose in order to provide enough PTV coverage.
Furthermore, all patients were treated in supine position in our study, while literature47, 48
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has shown that breast irradiation in prone position may result in lower risk of cardiac
toxicity and improve dose homogeneity within PTV compared to standard irradiation in
supine position. Further studies are needed to evaluate advanced WBRT techniques in prone
treatment position.
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In order to further reduce heart irradiation, deep inspiration breath hold (DIBH) has been
implemented for WBRT and studies have shown that DIBH can minimize irradiation of
heart without compromise target coverage for most left-sided breast cancer patient49–55.
However, not all patients could benefit from it, e.g. Dell’Oro et al.56 recently reported that
DIBH may not be recommended for some patients due to little dosimetric benefit. Several
studies54, 56, 57 reported criteria of selecting breast cancer patients for DIBH, including
patient’s age, ability to hold breath for a specific duration of time, total lung volume, in-field
heart volume, sternal excursion etc. In our study, the fifteen patients were not selected for
DIBH in the clinic mainly due to the limited dosimetric benefit for them. The benefit of
various WBRT techniques for DIBH patients will be investigated by our group in the near
future.
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One limitation of our study is that we did not compare the WBRT techniques in terms of
planning or treatment time, quality assurance (QA) workload, and patient’s comfort. Among
the seven WBRT techniques analyzed in this study, the delivery efficiency may be a concern
for non-coplanar VMAT plans,44, 58 and the rotation of gantry and couch between beams can
take considerable amount of time. The delivery time for non-coplanar plans can be shorten
by implementing the automated machine transitions between beams, e.g., Liang et al.18
illustrated that coronal VMAT which had dynamic patient couch rotation can be delivered in
4.5 minutes for a 3.85 Gy fraction for accelerated partial breast irradiation. Moreover, IMRT,
STD-VMAT, NC-VMAT and MA-VMAT require more MUs than SOC, FIF and hybrid
IMRT, as shown in Table 1. The increased number of MUs will inevitably result in longer
treatment time and increased leakage radiation which may increase patient’s discomfort and
risk of developing radiogenic side effects. The planning time for the seven WBRT
techniques was comparable. Contouring for one patient took 60 minutes on average, and
treatment planning for a patient using one technique took another 45 minutes on average,
which is comparable to the literature,7 except for MA-VMAT which needed slightly longer
planning time (about 60 minutes) due to increased small fields that required longer
optimization time to achieve the objectives. Hybrid IMRT, IMRT, STD-VMAT, NC-VMAT
and MA-VMAT all require QA of dosimetric output for every treatment plan,59 and NCVMAT requires extra specific QA procedures on couth rotation which may further increase
the workload of patient’s specific QA.60
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Conclusions
Seven WBRT techniques were evaluated in this study. Among them, NC-VMAT was
evaluated for WBRT for the first time and showed excellent sparing of lung and heart, STDVMAT could reduce dose to the contralateral breast, and MA-VMAT showed the best OAR
sparing. MA-VMAT and NC-VMAT might be the appropriate WBRT techniques for early
stage breast cancer patients after breast conserving surgery.

Med Dosim. Author manuscript; available in PMC 2021 July 07.

Xie et al.

Page 8

Author Manuscript

Acknowledgement
This work was partially supported by National Institutes of Health (NIH) through a National Cancer Institute (NCI)
grant K22CA204464 and Louisiana State University (LSU) Economic Development Assistantship Award.

References

Author Manuscript
Author Manuscript
Author Manuscript

1. Smith BD, Bellon JR, Blitzblau R, Freedman G, Haffty B, Hahn C, Halberg F, Hoffman K, Horst K,
Moran J, Patton C, Perlmutter J, Warren L, Whelan T, Wright JL and Jagsi R, “Radiation therapy
for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO)
evidence-based guideline,” Pract Radiat Oncol 8, 145–152 (2018). [PubMed: 29545124]
2. Halperin EC, Perez CA and Brady LW, Perez and Brady’s Principles and Practice of Radiation
Oncology, 5th Edition (LWW, Philadelphia, PA, 2008).
3. Cox JD and Ang KK, Radiation Oncology: rationale, technique, results. 9th ed (MOSBY
ELSEVIER, Philadelphia, PA, 2010).
4. Moody AM, Mayles WP, Bliss JM, A’Hern RP, Owen JR, Regan J, Broad B and Yarnold JR, “The
influence of breast size on late radiation effects and association with radiotherapy dose
inhomogeneity,” Radiother Oncol 33, 106–112 (1994). [PubMed: 7708953]
5. Goldsmith C, Haviland J, Tsang Y, Sydenham M and Yarnold J, “Large breast size as a risk factor
for late adverse effects of breast radiotherapy: is residual dose inhomogeneity, despite 3D treatment
planning and delivery, the main explanation?,” Radiother Oncol 100, 236–240 (2011). [PubMed:
21296441]
6. Lo YC, Yasuda G, Fitzgerald TJ and Urie MM, “Intensity modulation for breast treatment using
static multi-leaf collimators,” Int J Radiat Oncol Biol Phys 46, 187–194 (2000). [PubMed:
10656392]
7. Beckham WA, Popescu CC, Patenaude VV, Wai ES and Olivotto IA, “Is multibeam IMRT better
than standard treatment for patients with left-sided breast cancer?,” Int J Radiat Oncol Biol Phys 69,
918–924 (2007). [PubMed: 17889273]
8. Freedman GM, Anderson PR, Li J, Eisenberg DF, Hanlon AL, Wang L and Nicolaou N, “Intensity
modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for
breast cancer,” Am J Clin Oncol 29, 66–70 (2006). [PubMed: 16462506]
9. Farace P, Zucca S, Solla I, Fadda G, Durzu S, Porru S, Meleddu G, Deidda MA, Possanzini M, Orru
S and Lay G, “Planning hybrid intensity modulated radiation therapy for whole-breast irradiation,”
Int J Radiat Oncol Biol Phys 84, e115–122 (2012). [PubMed: 22543199]
10. Jeulink M, Dahele M, Meijnen P, Slotman BJ and Verbakel WF, “Is there a preferred IMRT
technique for left-breast irradiation?,” J Appl Clin Med Phys 16, 5266 (2015). [PubMed:
26103488]
11. Mayo CS, Urie MM and Fitzgerald TJ, “Hybrid IMRT plans--concurrently treating conventional
and IMRT beams for improved breast irradiation and reduced planning time,” Int J Radiat Oncol
Biol Phys 61, 922–932 (2005). [PubMed: 15708276]
12. Popescu CC, Olivotto IA, Beckham WA, Ansbacher W, Zavgorodni S, Shaffer R, Wai ES and Otto
K, “Volumetric modulated arc therapy improves dosimetry and reduces treatment time compared
to conventional intensity-modulated radiotherapy for locoregional radiotherapy of left-sided breast
cancer and internal mammary nodes,” Int J Radiat Oncol Biol Phys 76, 287–295 (2010). [PubMed:
19775832]
13. Tsai PF, Lin SM, Lee SH, Yeh CY, Huang YT, Lee CC and Hong JH, “The feasibility study of
using multiple partial volumetric-modulated arcs therapy in early stage left-sided breast cancer
patients,” J Appl Clin Med Phys 13, 3806 (2012). [PubMed: 22955645]
14. Xie Y, Bourgeois D, Guo B and Zhang R, “Postmastectomy radiotherapy for left-sided breast
cancer patients: Comparison of advanced techniques,” Med Dosim 45, 34–40 (2020). [PubMed:
31129035]
15. Shaitelman SF, Kim LH, Yan D, Martinez AA, Vicini FA and Grills IS, “Continuous arc rotation of
the couch therapy for the delivery of accelerated partial breast irradiation: a treatment planning
analysis,” Int J Radiat Oncol Biol Phys 80, 771–778 (2011). [PubMed: 20584586]

Med Dosim. Author manuscript; available in PMC 2021 July 07.

Xie et al.

Page 9

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

16. Popescu CC, Beckham WA, Patenaude VV, Olivotto IA and Vlachaki MT, “Simultaneous couch
and gantry dynamic arc rotation (CG-Darc) in the treatment of breast cancer with accelerated
partial breast irradiation (APBI): a feasibility study,” J Appl Clin Med Phys 14, 4035 (2013).
[PubMed: 23318391]
17. Fahimian B, Yu V, Horst K, Xing L and Hristov D, “Trajectory modulated prone breast irradiation:
a LINAC-based technique combining intensity modulated delivery and motion of the couch,”
Radiother Oncol 109, 475–481 (2013). [PubMed: 24231240]
18. Liang J, Atwood T, von Eyben R, Fahimian B, Chin E, Horst K, Otto K and Hristov D, “Trajectory
Modulated Arc Therapy: A Fully Dynamic Delivery With Synchronized Couch and Gantry Motion
Significantly Improves Dosimetric Indices Correlated With Poor Cosmesis in Accelerated Partial
Breast Irradiation,” Int J Radiat Oncol Biol Phys 92, 1148–1156 (2015). [PubMed: 26050608]
19. Jin GH, Chen LX, Deng XW, Liu XW, Huang Y and Huang XB, “A comparative dosimetric study
for treating left-sided breast cancer for small breast size using five different radiotherapy
techniques: conventional tangential field, filed-in-filed, tangential-IMRT, multi-beam IMRT and
VMAT,” Radiat Oncol 8, 89 (2013). [PubMed: 23587298]
20. Zhao H, He M, Cheng G, Han D, Wu N, Shi D, Zhao Z and Jin J, “A comparative dosimetric study
of left sided breast cancer after breast-conserving surgery treated with VMAT and IMRT,” Radiat
Oncol 10, 231 (2015). [PubMed: 26577189]
21. Han EY, Paudel N, Sung J, Yoon M, Chung WK and Kim DW, “Estimation of the risk of secondary
malignancy arising from whole-breast irradiation: comparison of five radiotherapy modalities,
including TomoHDA,” Oncotarget 7, 22960–22969 (2016). [PubMed: 27027239]
22. Schubert LK, Gondi V, Sengbusch E, Westerly DC, Soisson ET, Paliwal BR, Mackie TR, Mehta
MP, Patel RR, Tome WA and Cannon GM, “Dosimetric comparison of left-sided whole breast
irradiation with 3DCRT, forward-planned IMRT, inverse-planned IMRT, helical tomotherapy, and
topotherapy,” Radiother Oncol 100, 241–246 (2011). [PubMed: 21316783]
23. Xie X, Ouyang S, Wang H, Yang W, Jin H, Hu B and Shen L, “Dosimetric comparison of left-sided
whole breast irradiation with 3D-CRT, IP-IMRT and hybrid IMRT,” Oncol Rep 31, 2195–2205
(2014). [PubMed: 24604635]
24. Shiau AC, Hsieh CH, Tien HJ, Yeh HP, Lin CT, Shueng PW and Wu LJ, “Left-sided whole breast
irradiation with hybrid-IMRT and helical tomotherapy dosimetric comparison,” Biomed Res Int
2014, 741326 (2014). [PubMed: 25170514]
25. Haciislamoglu E, Colak F, Canyilmaz E, Dirican B, Gurdalli S, Yilmaz AH, Yoney A and Bahat Z,
“Dosimetric comparison of left-sided whole-breast irradiation with 3DCRT, forward-planned
IMRT, inverse-planned IMRT, helical tomotherapy, and volumetric arc therapy,” Phys Med 31,
360–367 (2015). [PubMed: 25733372]
26. Viren T, Heikkila J, Myllyoja K, Koskela K, Lahtinen T and Seppala J, “Tangential volumetric
modulated arc therapy technique for left-sided breast cancer radiotherapy,” Radiat Oncol 10, 79
(2015). [PubMed: 25888866]
27. Zhang HW, Hu B, Xie C and Wang YL, “Dosimetric comparison of three intensity-modulated
radiation therapies for left breast cancer after breast-conserving surgery,” J Appl Clin Med Phys
19, 79–86 (2018).
28. Xu Y, Wang J, Hu Z, Tian Y, Ma P, Li S, Dai J and Wang S, “Locoregional irradiation including
internal mammary nodal region for left-sided breast cancer after breast conserving surgery:
Dosimetric evaluation of 4 techniques,” Med Dosim (2018).
29. Allen Li X, Alber M, Deasy JO, Jackson A, Ken Jee KW, Marks LB, Martel MK, Mayo C,
Moiseenko V, Nahum AE, Niemierko A, Semenenko VA and Yorke ED, “The use and QA of
biologically related models for treatment planning: short report of the TG-166 of the therapy
physics committee of the AAPM,” Med Phys 39, 1386–1409 (2012). [PubMed: 22380372]
30. Newhauser WD, Jones T, Swerdloff S, Newhauser W, Cilia M, Carver R, Halloran A and Zhang R,
“Anonymization of DICOM electronic medical records for radiation therapy,” Computers in
Biology and Medicine 53, 134–140 (2014). [PubMed: 25147130]
31. Marks LB, Bentzen SM, Deasy JO, Kong FM, Bradley JD, Vogelius IS, El Naqa I, Hubbs JL,
Lebesque JV, Timmerman RD, Martel MK and Jackson A, “Radiation dose-volume effects in the
lung,” Int J Radiat Oncol Biol Phys 76, S70–76 (2010). [PubMed: 20171521]

Med Dosim. Author manuscript; available in PMC 2021 July 07.

Xie et al.

Page 10

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

32. Hardenbergh PH, Munley MT, Bentel GC, Kedem R, Borges-Neto S, Hollis D, Prosnitz LR and
Marks LB, “Cardiac perfusion changes in patients treated for breast cancer with radiation therapy
and doxorubicin: preliminary results,” Int J Radiat Oncol Biol Phys 49, 1023–1028 (2001).
[PubMed: 11240243]
33. Nicolini G, Fogliata A and Cozzi L, “Critical appraisal of a non-coplanar technique for
radiotherapy of breast minimising lung involvement,” Radiother Oncol 76, 319–325 (2005).
[PubMed: 15921771]
34. Wu Q, Mohan R, Morris M, Lauve A and Schmidt-Ullrich R, “Simultaneous integrated boost
intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas.
I: dosimetric results,” Int J Radiat Oncol Biol Phys 56, 573–585 (2003). [PubMed: 12738335]
35. van’t Riet A, Mak AC, Moerland MA, Elders LH and van der Zee W, “A conformation number to
quantify the degree of conformality in brachytherapy and external beam irradiation: application to
the prostate,” Int J Radiat Oncol Biol Phys 37, 731–736 (1997). [PubMed: 9112473]
36. National Research Council Health Risks from Exposure to Low Levels of Ionizing Radation: BEIR
VII - Phase 2. Washington, DC: The National Academies Press, 2006.
37. Schneider U, Sumila M and Robotka J, “Site-specific dose-response relationships for cancer
induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to
radiotherapy,” Theor Biol Med Model 8, 27 (2011). [PubMed: 21791103]
38. Lyman JT, “Complication probability as assessed from dose-volume histograms,” Radiat Res Suppl
8, S13–19 (1985). [PubMed: 3867079]
39. Kutcher GJ and Burman C, “Calculation of complication probability factors for non-uniform
normal tissue irradiation: the effective volume method,” Int J Radiat Oncol Biol Phys 16, 1623–
1630 (1989). [PubMed: 2722599]
40. Seppenwoolde Y, Lebesque JV, de Jaeger K, Belderbos JS, Boersma LJ, Schilstra C, Henning GT,
Hayman JA, Martel MK and Ten Haken RK, “Comparing different NTCP models that predict the
incidence of radiation pneumonitis. Normal tissue complication probability,” Int J Radiat Oncol
Biol Phys 55, 724–735 (2003). [PubMed: 12573760]
41. Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D, Correa C, Cutter D,
Gagliardi G, Gigante B, Jensen MB, Nisbet A, Peto R, Rahimi K, Taylor C and Hall P, “Risk of
ischemic heart disease in women after radiotherapy for breast cancer,” N Engl J Med 368, 987–
998 (2013). [PubMed: 23484825]
42. Ridker PM, Buring JE, Rifai N and Cook NR, “Development and validation of improved
algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score,”
JAMA 297, 611–619 (2007). [PubMed: 17299196]
43. Descovich M, Fowble B, Bevan A, Schechter N, Park C and Xia P, “Comparison between hybrid
direct aperture optimized intensity-modulated radiotherapy and forward planning intensitymodulated radiotherapy for whole breast irradiation,” Int J Radiat Oncol Biol Phys 76, 91–99
(2010). [PubMed: 19395189]
44. Smyth G, Evans PM, Bamber JC and Bedford JL, “Recent developments in non-coplanar
radiotherapy,” Br J Radiol 92, 20180908 (2019). [PubMed: 30694086]
45. Taylor C, Correa C, Duane FK, Aznar MC, Anderson SJ, Bergh J, Dodwell D, Ewertz M, Gray R,
Jagsi R, Pierce L, Pritchard KI, Swain S, Wang Z, Wang Y, Whelan T, Peto R and McGale P,
“Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to
the Lungs and Heart and From Previous Randomized Trials,” J Clin Oncol 35, 1641–1649 (2017).
[PubMed: 28319436]
46. Hooning MJ, Botma A, Aleman BM, Baaijens MH, Bartelink H, Klijn JG, Taylor CW and van
Leeuwen FE, “Long-term risk of cardiovascular disease in 10-year survivors of breast cancer,” J
Natl Cancer Inst 99, 365–375 (2007). [PubMed: 17341728]
47. Merchant TE and McCormick B, “Prone position breast irradiation,” Int J Radiat Oncol Biol Phys
30, 197–203 (1994). [PubMed: 8083114]
48. Stegman LD, Beal KP, Hunt MA, Fornier MN and McCormick B, “Long-term clinical outcomes of
whole-breast irradiation delivered in the prone position,” Int J Radiat Oncol Biol Phys 68, 73–81
(2007). [PubMed: 17337131]

Med Dosim. Author manuscript; available in PMC 2021 July 07.

Xie et al.

Page 11

Author Manuscript
Author Manuscript
Author Manuscript

49. Bruzzaniti V, Abate A, Pinnaro P, D’Andrea M, Infusino E, Landoni V, Soriani A, Giordano C,
Ferraro A and Strigari L, “Dosimetric and clinical advantages of deep inspiration breath-hold
(DIBH) during radiotherapy of breast cancer,” J Exp Clin Cancer Res 32, 88 (2013). [PubMed:
24423396]
50. Yeung R, Conroy L, Long K, Walrath D, Li H, Smith W, Hudson A and Phan T, “Cardiac dose
reduction with deep inspiration breath hold for left-sided breast cancer radiotherapy patients with
and without regional nodal irradiation,” Radiat Oncol 10, 200 (2015). [PubMed: 26391237]
51. Smyth LM, Knight KA, Aarons YK and Wasiak J, “The cardiac dose-sparing benefits of deep
inspiration breath-hold in left breast irradiation: a systematic review,” J Med Radiat Sci 62, 66–73
(2015). [PubMed: 26229669]
52. Vikstrom J, Hjelstuen MH, Mjaaland I and Dybvik KI, “Cardiac and pulmonary dose reduction for
tangentially irradiated breast cancer, utilizing deep inspiration breath-hold with audio-visual
guidance, without compromising target coverage,” Acta Oncol 50, 42–50 (2011). [PubMed:
20843181]
53. Osman SO, Hol S, Poortmans PM and Essers M, “Volumetric modulated arc therapy and breathhold in image-guided locoregional left-sided breast irradiation,” Radiother Oncol 112, 17–22
(2014). [PubMed: 24825176]
54. Latty D, Stuart KE, Wang W and Ahern V, “Review of deep inspiration breath-hold techniques for
the treatment of breast cancer,” J Med Radiat Sci 62, 74–81 (2015). [PubMed: 26229670]
55. Remouchamps VM, Vicini FA, Sharpe MB, Kestin LL, Martinez AA and Wong JW, “Significant
reductions in heart and lung doses using deep inspiration breath hold with active breathing control
and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation,”
Int J Radiat Oncol Biol Phys 55, 392–406 (2003). [PubMed: 12527053]
56. Dell’Oro M, Giles E, Sharkey A, Borg M, Connell C and Bezak E, “A Retrospective Dosimetric
Study of Radiotherapy Patients with Left-Sided Breast Cancer; Patient Selection Criteria for Deep
Inspiration Breath Hold Technique,” Cancers (Basel) 11 (2019).
57. Kim T, Reardon K, Trifiletti DM, Geesey C, Sukovich K, Crandley E, Read PW and Wijesooriya
K, “How dose sparing of cardiac structures correlates with in-field heart volume and sternal
displacement,” J Appl Clin Med Phys 17, 60–68 (2016).
58. Yu VY, Landers A, Woods K, Nguyen D, Cao M, Du D, Chin RK, Sheng K and Kaprealian TB, “A
Prospective 4pi Radiation Therapy Clinical Study in Recurrent High-Grade Glioma Patients,” Int J
Radiat Oncol Biol Phys 101, 144–151 (2018). [PubMed: 29619962]
59. Ezzell GA, Galvin JM, Low D, Palta JR, Rosen I, Sharpe MB, Xia P, Xiao Y, Xing L and Yu CX,
“Guidance document on delivery, treatment planning, and clinical implementation of IMRT: report
of the IMRT Subcommittee of the AAPM Radiation Therapy Committee,” Med Phys 30, 2089–
2115 (2003). [PubMed: 12945975]
60. Yu VY, Fahimian BP, Xing L and Hristov DH, “Quality control procedures for dynamic treatment
delivery techniques involving couch motion,” Med Phys 41, 081712 (2014). [PubMed: 25086522]

Author Manuscript
Med Dosim. Author manuscript; available in PMC 2021 July 07.

Xie et al.

Page 12

Author Manuscript
Author Manuscript
Author Manuscript
Fig. 1.

Author Manuscript

Axial view of isodose distribution for SOC, FIF, Hybrid IMRT, IMRT, STD-VMAT, NCVMAT and MA-VMAT plans for a typical WBRT patient. The red color wash represents the
PTV-Eval.
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Fig. 2.

DVHs for SOC, FIF, Hybrid IMRT, IMRT, STD-VMAT, NC-VMAT and MA-VMAT plans
for a typical WBRT patient.
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MU, PTV and OAR evaluation metrics (mean ± standard deviation). DHI values have more significant figures
to show the difference among different techniques. SOC: standard of care; FIF: field in field; Hybrid: hybrid
intensity-modulated radiation therapy; IMRT: intensity-modulated radiation therapy; STD-VMAT: standard
volumetric modulated arc therapy; NC-VMAT: non-coplanar VMAT; MA-VMAT: multiple arc VMAT; MU:
monitor unit; PTV: planning target volume; DHI: Dose homogeneity index; CL breast: contralateral breast.
LAR: lifetime attributable risk; RCE: risk of coronary events; NTCP: normal tissue complication probability.
SOC

Hybrid

IMRT

STD-VMAT

NC-VMAT

MA-VMAT

7343±962

5647±227

8673±1506

19300±2471

10263±1049

10397±1549

11523±1167

Dmean (Gy)

50.7±0.7

50.6±0.5

50.4±0.6

50.1±0.3

50.0 ±0.4

49.9±0.4

50.0±0.4

Dmax (Gy)

55.5±1.7

53.8±0.9

53.8±0.9

56.7±0.9

55.0±1.4

54.7±1.0

55.2±1.3

V107% (%)

0.1±0.1

0.0±0.1

0.0±0.1

0.0±0.0

0.0±0.0

0.0±0.0

0.0±0.0

Average total MU

FIF

PTV

Author Manuscript

CI

0.5±0.1

0.5±0.1

0.6±0.1

0.8±0.1

0.8±0.1

0.8±0.1

0.8±0.1

0.150±0.033

0.132±0.021

0.126±0.024

0.142±0.029

0.157±0.056

0.158±0.044

0.164±0.046

Dmean (Gy)

6.7±1.0

6.4±0.8

6.1±1.0

5.9±0.9

6.0±0.9

5.4±1.1

4.9±0.9

Dmax (Gy)

53.3±1.7

51.4±1.4

50.3±1.5

48.3±1.5

47.9±2.3

46.2±4.1

50.8±2.8

V5

18.3±2.2

18.6±2.3

17.7±2.0

26.4±5.0

27.0±7.1

24.8±8.2

19.6±4.2

V10

14.8±2.0

15.0±2.2

14.4±2.0

15.1±3.1

14.3±2.7

12.8±3.6

12.5±3.3

V20

12.7±2.0

12.6±2.1

12.2±1.9

7.9±2.6

7.8±1.6

6.6±1.9

7.3±1.6

NTCP (%)

1.8±0.4

1.7±0.4

1.6±0.3

1.5±0.3

1.5±0.3

1.3±0.3

1.2±0.2

LAR (%)

2.2±0.4

2.2±0.4

2.0±0.3

2.0±0.3

2.0±0.4

1.8±0.4

1.7±0.3

DHI
Total lung

Heart

Author Manuscript

Dmean (Gy)

9.6±3.7

8.1±3.7

8.1±2.8

7.4±1.3

7.8± 1.5

5.8±1.0

5.5±1.2

Dmax (Gy)

51.7±2.2

50.1±1.7

49.3±1.4

43.7±6.2

44.5±3.3

41.0±5.4

45.0±4.1

V5

25.3±10.1

25.7±9.4

23.9±8.7

48.3±14.0

53.2±8.5

30.5±9.0

22.1±9.0

V10

19.8±8.8

19.0±8.0

18.4±7.7

20.1±4.9

18.7±5.7

11.7±3.5

9.7±2.7

V22.5

16.6±8.0

14.9±6.9

14.7±6.6

4.7±3.2

6.2±2.7

4.3±1.9

5.0±1.8

V30

15.1±7.5

13.3±6.4

12.7±5.9

2.7±2.9

3.9±2.2

2.0±1.4

3.2±1.9

RCE (%)

12.4±3.5

11.5±3.1

11.6±3.1

11.4±3.3

11.6±3.2

10.5±2.8

10.3±2.7

CL breast

Author Manuscript

Dmean (Gy)

2.8±2.5

1.9±1.8

1.6±1.2

1.4±0.7

1.1±0.3

1.2±0.7

1.2±0.4

Dmax (Gy)

48.3±7.2

45.6±6.8

42.8±6.7

17.0±4.3

7.3±4.9

10.3±8.5

12.0±8.3

V5

4.2±2.6

3.8±3.0

4.0±3.0

0.2±0.3

0.3±0.7

0.2±0.5

0.1±0.1

LAR (%)

5.8±4.9

5.7±2.7

5.3±4.7

4.8±2.4

4.1±1.4

4.1±2.2

3.9± 1.3
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V5

Dmax

Dmean

CL breast

RCE (%)

V30

V22.5

V10

V5

Dmax

Dmean

Heart

LAR (%)

NTCP

V20

V10

V5

Dmax

Dmean

Lung

DHI

CI

V107% (%)

Dmax

Dmean

PTV

Variable

SOC
vs FIF

SOC vs
Hybrid

SOC vs
IMRT

SOC vs
STDVMAT

SOC vs
NCVMAT

SOC vs
MAVMAT

FIF vs
Hybrid

FIF vs
IMRT

FIF vs
STDVMAT

FIF vs
NCVMAT

FIF vs
MAVMAT
Hybrid
vs IMRT

Hybrid vs
STDVMAT

Hybrid vs
NCVMAT

Hybrid vs
MAVMAT

IMRT vs
STDVMAT

Author Manuscript

Statistic comparison of seven WBRT techniques using post hoc Tukey test. Grey color indicates statistically significant (p values <0.05)
IMRT vs
NCVMAT

IMRT vs
MAVMAT

STDVMAT vs
NCVMAT

STDVMAT vs
MAVMAT

Author Manuscript

Table 2.

NCVMAT vs
MAVMAT
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LAR (%)

SOC vs
STDVMAT

SOC vs
NCVMAT

SOC vs
MAVMAT

FIF vs
Hybrid

Author Manuscript

SOC vs
IMRT

FIF vs
IMRT

FIF vs
STDVMAT

FIF vs
NCVMAT

FIF vs
MAVMAT

Author Manuscript

SOC vs
Hybrid

Hybrid
vs IMRT

Hybrid vs
STDVMAT

Hybrid vs
NCVMAT

Hybrid vs
MAVMAT

IMRT vs
STDVMAT

Author Manuscript

SOC
vs FIF

IMRT vs
NCVMAT

IMRT vs
MAVMAT

STDVMAT vs
NCVMAT

STDVMAT vs
MAVMAT

Author Manuscript

Variable

NCVMAT vs
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Comparison with previous WBRT planning studies that have the same PTV definition as ours.
Reference
Descovich et al.
(2010)

Num. of
patients

Breast
site
Left

15

Schubert et al. (2011)

FIF, hybrid IMRT
Left
SOC, FIF, tangential IMRT (2 Fields),
TOMO, topotherapy

10

Jin et al. (2013)

Left
20

Viren et al. (2015)

Left
10

Author Manuscript

Haciislamoglu et al.
(2015)

Techniques compared

10

Zhang et al. (2018)

Tangential IMRT is recommended since it has
improved DHI and reduced dose to heart and
lung.
Both VMAT techniques show improved DHI
and better sparing of heart and ipsilateral lung.
Continuous VMAT provides best dose coverage
at the cost of significantly increased dose to
contralateral breast.
TOMO shown reduced high and mean doses to
heart and lung at the cost of increased low dose
cloud.

Left and
right

SOC, FIF, IMRT (10 to 12 fields),
VMAT (3–4 partial arcs spanned from
305° to 152° for the left, 60° to 214°
for the right), TOMO

TOMO is recommended since it provides the
lowest LAR for all surrounding OARs.

Left

Left
15

TOMO, topotherapy and tangential IMRT can
reduce high dose to target and normal tissue;
TOMO results in increased low doses to normal
tissue.

SOC, FIF, 9-field IMRT, TOMO,
VMAT (Starting and ending angles of
the arcs were 10° posterior to
tangential fields)

50
Our study

FIF, tangential IMRT (2 Fields),
tangential VMAT (two dual arcs of
50°–60°), continuous VMAT (dual arc
of 240°)

Hybrid IMRT is preferred since it can reduce
hot spot, provide better coverage and require
less planning time.

Left
15

Han et al. (2016)

SOC, FIF, tangential IMRT (2 Fields),
IMRT (7 Fields), VMAT (starting and
ending angles were same as tangential
beam angles)

Key findings

5-field IMRT, 6-field IMRT, FIFDMPO-IMRT
SOC, FIF, hybrid, IMRT, VMAT
(starting and ending angle were same
as tangential beam angles), MAVMAT, NC-VMAT

FIF-DMPO-IMRT is recommended due to
reduced heart and lung doses and treatment
time.
MA-VMAT and NC-VMAT are recommended
due to reduced doses and risks for heart, lung
and contralateral breast.
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